476 related articles for article (PubMed ID: 16930211)
21. Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence.
Kampman KM; Pettinati HM; Lynch KG; Xie H; Dackis C; Oslin DW; Sparkman T; Sharkoski T; O'Brien CP
Addict Behav; 2009; 34(6-7):581-6. PubMed ID: 19345510
[TBL] [Abstract][Full Text] [Related]
22. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
Mason BJ
J Clin Psychiatry; 2001; 62 Suppl 20():42-8. PubMed ID: 11584875
[TBL] [Abstract][Full Text] [Related]
23. Acamprosate decreases the hypermotility during repeated ethanol withdrawal.
Dahchour A; De Witte P
Alcohol; 1999 May; 18(1):77-81. PubMed ID: 10386669
[TBL] [Abstract][Full Text] [Related]
24. Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.
Ralevski E; O'Brien E; Jane JS; Dean E; Dwan R; Petrakis I
J Nerv Ment Dis; 2011 Jul; 199(7):499-505. PubMed ID: 21716064
[TBL] [Abstract][Full Text] [Related]
25. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.
Diehl A; Ulmer L; Mutschler J; Herre H; Krumm B; Croissant B; Mann K; Kiefer F
Alcohol Alcohol; 2010; 45(3):271-7. PubMed ID: 20348436
[TBL] [Abstract][Full Text] [Related]
26. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol.
Paille FM; Guelfi JD; Perkins AC; Royer RJ; Steru L; Parot P
Alcohol Alcohol; 1995 Mar; 30(2):239-47. PubMed ID: 7662044
[TBL] [Abstract][Full Text] [Related]
27. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
28. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
Scott LJ; Figgitt DP; Keam SJ; Waugh J
CNS Drugs; 2005; 19(5):445-64. PubMed ID: 15907154
[TBL] [Abstract][Full Text] [Related]
29. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
30. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
Kotlinska J; Bochenski M
Eur J Pharmacol; 2008 Nov; 598(1-3):57-63. PubMed ID: 18838071
[TBL] [Abstract][Full Text] [Related]
31. Acamprosate in the treatment of alcohol dependence: clinical and economic considerations.
Mason BJ; Crean R
Expert Rev Neurother; 2007 Nov; 7(11):1465-77. PubMed ID: 17997696
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study.
Pelc I; Verbanck P; Le Bon O; Gavrilovic M; Lion K; Lehert P
Br J Psychiatry; 1997 Jul; 171():73-7. PubMed ID: 9328500
[TBL] [Abstract][Full Text] [Related]
33. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
[TBL] [Abstract][Full Text] [Related]
34. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin.
Malcolm R; Myrick LH; Veatch LM; Boyle E; Randall PK
J Clin Sleep Med; 2007 Feb; 3(1):24-32. PubMed ID: 17557449
[TBL] [Abstract][Full Text] [Related]
35. Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference.
Zalewska-Kaszubska J; Górska D; Dyr W; Czarnecka E
Neurosci Lett; 2008 Feb; 431(3):221-5. PubMed ID: 18162308
[TBL] [Abstract][Full Text] [Related]
36. Acamprosate: A Review of Its Use in Alcohol Dependence.
Plosker GL
Drugs; 2015 Jul; 75(11):1255-68. PubMed ID: 26084940
[TBL] [Abstract][Full Text] [Related]
37. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
38. Acamprosate for alcohol dependence?
Drug Ther Bull; 1997 Sep; 35(9):70-2. PubMed ID: 9350085
[No Abstract] [Full Text] [Related]
39. Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.
Kranzler HR; Gage A
Am J Addict; 2008; 17(1):70-6. PubMed ID: 18214726
[TBL] [Abstract][Full Text] [Related]
40. Influence of age at drinking onset on the alcohol deprivation effect and stress-induced drinking in female rats.
Füllgrabe MW; Vengeliene V; Spanagel R
Pharmacol Biochem Behav; 2007 Feb; 86(2):320-6. PubMed ID: 17098280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
